A new study reports that the macrophage enzyme MMP14 generates soluble semaphorin 4D, helping build an immunosuppressive tumor microenvironment that excludes anti-cancer T cells. The findings connect macrophage matrix remodeling activity to immune trafficking and persistence barriers. By identifying an upstream macrophage-driven signal, the research points to combination opportunities where blocking the MMP14–semaphorin axis could improve T-cell infiltration and checkpoint response rates. For immuno-oncology development, this adds a functional bridge between innate tumor-associated macrophage activity and adaptive immune access within the tumor bed.